FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Etoposide Phosphate (Etopophos) Injection
Status: Currently in Shortage
»Date first posted: 09/16/2016
»Therapeutic Categories: Oncology

Bristol Myers Squibb Co. (New 09/16/2016)

Company Contact Information:

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Etopophos Injection 100 mg (1VL) 10.6 mL US (NDC 0015-3404-20) The product is currently on backorder. The company is working to have this available as soon as possible. Estimated recovery: September 2017. Shortage per Manufacturer: shortage of API Shortage of active ingredient

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English